| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | -0.0062 | 0.9 |
| mRNA | Methotrexate | FIMM | pan-cancer | AAC | 0.018 | 0.9 |
| mRNA | Nilotinib | FIMM | pan-cancer | AAC | 0.024 | 0.9 |
| mRNA | Parthenolide | GDSC1000 | pan-cancer | AAC | -0.0081 | 0.9 |
| mRNA | BIRB 0796 | FIMM | pan-cancer | AAC | -0.022 | 0.9 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | 0.0045 | 0.9 |
| mRNA | Topotecan | FIMM | pan-cancer | AAC | -0.013 | 0.9 |
| mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | 0.0072 | 0.9 |
| mRNA | IC-87114 | CTRPv2 | pan-cancer | AAC | 0.0059 | 0.9 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | 0.0065 | 0.9 |